These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3096429)

  • 1. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Ganes T; Kierulf P; Smeland E; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1986 Nov; 293(6556):1195-9. PubMed ID: 3096429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-normoglycemia and late diabetic complications. The Oslo Study.
    Dahl-Jørgensen K
    Acta Endocrinol Suppl (Copenh); 1987; 284():1-38. PubMed ID: 3300128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy and renal involvement.
    Beck-Nielsen H; Olesen T; Mogensen CE; Richelsen B; Olsen HW; Ehlers N; Charles P; Sørensen NS
    Diabetes Res; 1990 Dec; 15(4):185-90. PubMed ID: 2132407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 36 months continuous subcutaneous insulin infusion (CSII) in insulin dependent diabetes (IDDM)--influence on early stages of retinopathy, nephropathy and neuropathy--psychological analysis.
    Bibergeil H; Hüttl I; Felsing W; Felsing U; Seidlein I; Herfurth S; Dabels J; Reichel G; Lüder C; Albrecht G
    Exp Clin Endocrinol; 1987 Aug; 90(1):51-61. PubMed ID: 3666060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII).
    Olsen T; Richelsen B; Ehlers N; Beck-Nielsen H
    Acta Ophthalmol (Copenh); 1987 Apr; 65(2):185-9. PubMed ID: 3300140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Steno study group.
    Lancet; 1982 Jan; 1(8264):121-4. PubMed ID: 6119509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous insulin infusion therapy and retinopathy in patients with type I diabetes.
    Helve E; Laatikainen L; Merenmies L; Koivisto VA
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):313-9. PubMed ID: 3303785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of six months continuous subcutaneous insulin infusion on kidney function and size in insulin-dependent diabetics.
    Christensen CK; Christiansen JS; Christensen T; Hermansen K; Mogensen CE
    Diabet Med; 1986 Jan; 3(1):29-32. PubMed ID: 2951131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy.
    Service FJ; Rizza RA; Daube JR; O'Brien PC; Dyck PJ
    Diabetologia; 1985 Oct; 28(10):722-7. PubMed ID: 3905469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII).
    Schmitz O; Sorensen SS; Alberti KG; Orskov H; Hansen HE
    J Diabet Complications; 1987; 1(3):81-6. PubMed ID: 2969910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic retinopathy after one year of improved metabolic control obtained by continuous subcutaneous insulin infusion (CSII).
    Olsen T; Ehlers N; Nielsen CB; Beck-Nielsen H
    Acta Ophthalmol (Copenh); 1985 Jun; 63(3):315-9. PubMed ID: 4036563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy.
    Lauritzen T; Frost-Larsen K; Larsen HW; Deckert T
    Diabetes; 1985 Aug; 34 Suppl 3():74-9. PubMed ID: 4018423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study.
    Dahl-Jørgensen K; Hanssen KF; Kierulf P; Bjøro T; Sandvik L; Aagenaes O
    Acta Endocrinol (Copenh); 1988 Jan; 117(1):19-25. PubMed ID: 3289293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1985 Mar; 290(6471):811-5. PubMed ID: 3919804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of plasma glucose control by continuous subcutaneous insulin infusion or conventional therapy on retinal morphology and urinary albumin excretion.
    Bell PM; Hayes JR; Hadden DR; Archer DB
    Diabete Metab; 1985 Aug; 11(4):254-61. PubMed ID: 3899766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy.
    Chiasson JL; Ducros F; Poliquin-Hamet M; Lopez D; Lecavalier L; Hamet P
    Diabetes Care; 1984; 7(4):331-7. PubMed ID: 6381006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus.
    Dahl-Jørgensen K; Bjøro T; Kierulf P; Sandvik L; Bangstad HJ; Hanssen KF
    Kidney Int; 1992 Apr; 41(4):920-3. PubMed ID: 1513113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM.
    Beck-Nielsen H; Richelsen B; Mogensen CE; Olsen T; Ehlers N; Nielsen CB; Charles P
    Diabetes Care; 1985; 8(6):585-9. PubMed ID: 4075944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.